000 01587 a2200361 4500
005 20250517023634.0
264 0 _c20161213
008 201612s 0 0 spa d
022 _a2171-8695
024 7 _a10.7399/fh.2015.39.2.8109
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCarreres-Prieto, Montserrat
245 0 0 _a[Interstitial lung disease induced by raltitrexed-oxaliplatin based chemotherapy for colorectal cancer: a case report].
_h[electronic resource]
260 _bFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_cMar 2015
300 _a118-9 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAged
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aColorectal Neoplasms
_xcomplications
650 0 4 _aHumans
650 0 4 _aLung Diseases, Interstitial
_xchemically induced
650 0 4 _aMale
650 0 4 _aOrganoplatinum Compounds
_xadministration & dosage
650 0 4 _aOxaliplatin
650 0 4 _aPrednisone
_xtherapeutic use
650 0 4 _aQuinazolines
_xadministration & dosage
650 0 4 _aThiophenes
_xadministration & dosage
700 1 _aLópez-Sisamón, David
700 1 _aLayos-Romero, Laura
773 0 _tFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_gvol. 39
_gno. 2
_gp. 118-9
856 4 0 _uhttps://doi.org/10.7399/fh.2015.39.2.8109
_zAvailable from publisher's website
999 _c24750013
_d24750013